Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke.
about
The Role of the Neuroprotective Factor Npas4 in Cerebral IschemiaInflammatory responses in hypoxic ischemic encephalopathyAdhesion molecules in CNS disorders: biomarker and therapeutic targetsThe science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future successLeucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled?The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury.Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repairInflammatory mechanisms in ischemic stroke: role of inflammatory cells.Leukocyte recruitment and ischemic brain injury.Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage.Pathophysiologic cascades in ischemic strokeNeutrophil elastase mediates acute pathogenesis and is a determinant of long-term behavioral recovery after traumatic injury to the immature brainAM-36 modulates the neutrophil inflammatory response and reduces breakdown of the blood brain barrier after endothelin-1 induced focal brain ischaemia.Targeting neutrophils in ischemic stroke: translational insights from experimental studies.Hypercholesterolemia: its impact on ischemia-reperfusion injury.A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke.Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.The inflammatory response in strokeTransient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats.GPER expressed on microglia mediates the anti-inflammatory effect of estradiol in ischemic stroke.IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke.Cell adhesion molecules and ischemic strokeRole of inflammation and its mediators in acute ischemic stroke.Peripheral Immune Cell Counts and Advanced Imaging as Biomarkers of Stroke Outcome.Inflammatory Disequilibrium in StrokeCerebral ischemic damage in diabetes: an inflammatory perspective.Inflammation in adult and neonatal stroke.Peripheral polymorphonuclear leukocyte activation as a systemic inflammatory response in ischemic stroke.Inflammatory responses in brain ischemia.Role of Circulating Immune Cells in Stroke and Preconditioning-Induced Protection.Immunity and stroke, the hurdles of stroke research translation.Leukocyte transendothelial migration: A local affair.The advantageous role of annexin A1 in cardiovascular disease.Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke.Neonatal brain injury and systemic inflammation: modulation by activated protein C ex vivo.Bone marrow chimeras in the study of experimental stroke.Stroke-associated inflammation: is von Willebrand factor a 'bad guy'?Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury.Polymorphonuclear neutrophil in brain parenchyma after experimental intracerebral hemorrhage.
P2860
Q26774448-29344F48-4383-41DB-9F8C-7675497BE71CQ27001711-C7D8AA03-47A1-4B32-9CD2-B9F518103A5DQ27015967-51785E23-2F75-486D-9654-EE281CB8DDDAQ28394257-BB568A60-17DD-4C42-ADC1-0E3657292F3AQ28396616-E31405FC-14D8-490C-B8D4-0A03660FFEA9Q30536373-E09AF771-3475-42C1-B209-05E9C4821928Q33583258-00067C9C-6353-4542-8FC9-EFA84AD1AB0EQ33806613-336EC95F-D31A-4673-9D74-A7E667C3EB25Q33886526-4315AC63-375A-4C87-8184-3FCFE57D2794Q33925611-DC981E41-5CFE-4DA3-A691-D5E0F05CE2AFQ34093771-B42947FD-60B3-4290-9FDD-674A9C0FF10FQ34282729-7395F34C-9C80-46EE-A3E1-81AA71F66443Q35070570-28AC2A6B-3D07-42CD-94C4-760D73E3E3C2Q36054388-403AE74B-56D1-485A-A5C9-025137873275Q36267227-DF5017AD-FC14-4F3D-A491-B728E6FD89D5Q36314857-6A47BC2D-EB5C-4682-9638-2B5E34C9E1B4Q36408695-DEED2E1A-BD98-4075-B3A6-23F3B065965FQ36484546-E864E51A-7372-4383-AA22-31E584179D61Q36692346-13DEA27D-FADA-4AC2-9D0D-5686A61A0E53Q36731657-1D283692-A7F1-47EA-899B-6B8ADE5E8911Q36824828-0F3D2439-6776-4D3A-AFBF-1C8F09512FF7Q37079682-2E9E8F83-64CD-4B82-9A2C-D5503C142EE0Q37282898-A147621C-44FA-4799-83E4-2BEF9E39C5E9Q37312790-27C28DEA-2F8C-4EA6-A229-3B7128F22D45Q37439479-AB84297F-3796-4054-8F1A-A1C1F03ADEDCQ37474699-9CB273E1-1994-48D1-81C0-854B2AAA1D86Q37602716-EB2FDFEC-D6CE-44FD-900D-77DF3D228E24Q37714376-33D9F2B3-1E22-4F5A-97BB-C09952FAE1BFQ38101834-CE86B258-444C-41F1-A4D3-42D0654A57ECQ38349993-58093903-30DC-4CD8-AB19-EDF36197F8E4Q38606473-1025A670-B763-40A7-A99E-1FA938F5B229Q38804651-1DDD3785-3A6E-45EF-905F-D4417D151C84Q38974938-987E728C-DAD7-44D4-8DAD-DFE1F9DDBDC7Q39012576-BF6080A8-B806-4DC6-A07D-21E7051181A7Q41314097-4420748E-163D-463D-80D7-26089CF94F3BQ41746195-A0C51646-F4D6-4282-9E34-EAE4CB0127CAQ46591953-6D2511A9-A948-428E-831D-6E356981A3A2Q48467902-599B1B28-DA88-4B68-BE00-D3BD320EEE05Q48516512-BA48DDA0-B544-48EE-B87F-6C79C70D70E2Q52649085-D6318792-5373-4CFC-9C22-FF3194916AD5
P2860
Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke.
@ast
Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke.
@en
Anti-leukocyte antibodies: LeukArrest
@nl
type
label
Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke.
@ast
Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke.
@en
Anti-leukocyte antibodies: LeukArrest
@nl
prefLabel
Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke.
@ast
Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke.
@en
Anti-leukocyte antibodies: LeukArrest
@nl
P1476
Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke
@en
P2093
Kyra J Becker
P304
P356
10.1185/030079902125000688
P407
P478
18 Suppl 2
P50
P577
2002-01-01T00:00:00Z